Back to search

University of British Columbia

Long-term outcomes of antibiotic treatments in fecal microbiota transplantation donors on microbiota composition, function, and antibiotic resistance genes

Abstract

dc:description

Fecal Microbiota Transplantation (FMT) serves as a primary treatment option for recurrent Clostridioides difficile Infection (rCDI) and is under clinical trial for diseases like Inflammatory Bowel Disease (IBD). Its core objective is to rebalance the gut microbiota, relying on the selection of safe donor samples. This choice is critical; a well-matched donor sample can restore healthy gut flora and facilitate treatment, while an unsuitable one might introduce dangerous pathogens. Amidst these considerations, a substantial knowledge gap exists concerning the consequences of antibiotic consumption by potential donors. Specifically, the effects of antibiotics on donor samples and their duration of impact, as well as the timeframe for reusing the same donors for FMT after antibiotic exposure, remain uncertain. This study investigates the antibiotic-induced alterations in donor samples, focusing on changes during and post-antibiotic treatment. I conducted a longitudinal analysis of samples from three donors, employing high-throughput metagenomics sequencing to assess the enduring effects of antibiotics on bacterial diversity, composition, functions, and the phageome. Results indicate substantial antibiotic impacts on the microbial community at species and strain levels, affecting key bacteria necessary for FMT success, including SCFA-producing bacteria like Eubacterium hallii and Bifidobacterium bifidum, which is also known as a highly engrafting bacterium. Moreover, antibiotics affect the functionality of the bacterial community, mainly affecting housekeeping genes. However, the relationship between these affected functional changes and FMT success remains unexplored. I also observed only minimal changes in viral populations, with their relevance to FMT success remaining unexplored. Additionally, no significant increase was found in the development of serious Antibiotic Resistance Genes (ARGs), which contrasts with my initial expectations of major shifts in ARGs. This study underscores the notion that donors who have previously consumed antibiotics may not be ideal candidates for subsequent FMT procedures and applications due to the changes occurring in their gut microbiota, which extend beyond alterations in ARGs. It's crucial to note that safety concerns regarding the accumulation of ARGs do not seem to be substantiated by findings of this study. Also, customizing suspension periods with detailed analysis can better gauge the microbiota's recovery.

Degree

thesis:*
Name thesis:degree_name
Master of Applied Science - MASc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Mechanical Engineering
Grantor dc:publisher
University of British Columbia
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Karimianghadim, Ramin
Contributors dc:contributor
  • Pakpour, Sepideh

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/87867

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Karimianghadim, Ramin. Long-term outcomes of antibiotic treatments in fecal microbiota transplantation donors on microbiota composition, function, and antibiotic resistance genes. master's thesis, University of British Columbia, 2024. http://hdl.handle.net/2429/87867